Skip to main content

Table 1 Mutations in the tau gene that are identified in FTDP-17 patients

From: Alternative splicing of exon 10 in the taugene as a target for treatment of tauopathies

Exon or intron

Mutations

EX1

Arg5His

EX9

Ile260Val; Leu266Val; Gly272Val

EX10

Asn279Lys; ΔK280; ΔK281; Asn296His; Pro301Thr; Pro301Ser; Pro301Leu; Gly303Val; Ser305Asn

EX11

Leu315Arg; Lys317Met; Ser320Phe

EX12

Gly335Ser; Gly335Val;Gln336Arg; Val363Ile; Val337Met; Glu342Val; Ser352Leu; Lys369Ile

EX13

Arg406Trp; Thr427Met

IVS9

-10G>T

EX10

Asn279Lys; ΔK280; Asn296; Leu284; Ser305, Asn296His; Pro301Thr

IVS10

+3G>A; +11T>C; +12C>T; +13A>G; +14C>T; +16C>T; +19C>G

  1. Data are derived from http://www.molgen.ua.ac.be/ftdmutations. Mutations in bold affect exon 10 splicing. IVS, intervening sequence.